Abstract
489Background: The introduction of thyrosinkinase inhibitors (TKI) changed the treatment of metastatic kidney cancer fundamentally. To elaborate the potential impact of TKI therapies, we studied tr...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have